Societal CDMO to Participate at 35th Annual Roth Conference
SAN DIEGO and GAINESVILLE, Ga., March 03, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will participate at the 35th Annual Roth Conference.
Related news for (SCTL)
- Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
- Societal CDMO Reports Inducement Grants for New Staff
- Societal CDMO Reports Third Quarter 2023 Financial Results
- Societal CDMO Enters Agreement With Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor Modulator
- Societal CDMO Reports Inducement Grants for New Staff